Cargando…
Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine
Connexin (Cx43)-formed channels have been linked to cardiac arrhythmias and diseases of the heart associated with myocardial tissue loss and fibrosis. These pathologies include ischemic heart disease, ischemia-reperfusion injury, heart failure, hypertrophic cardiomyopathy, arrhythmogenic right ventr...
Autores principales: | Marsh, Spencer R., Williams, Zachary J., Pridham, Kevin J., Gourdie, Robert G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147937/ https://www.ncbi.nlm.nih.gov/pubmed/34063001 http://dx.doi.org/10.3390/jcdd8050052 |
Ejemplares similares
-
Correction: Marsh et al. Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine. J. Cardiovasc. Dev. Dis. 2021, 8, 52
por: Marsh, Spencer R., et al.
Publicado: (2022) -
Connexin 43-Based Therapeutics for Dermal Wound Healing
por: Montgomery, Jade, et al.
Publicado: (2018) -
Connexin 43 confers chemoresistance through activating PI3K
por: Pridham, Kevin J., et al.
Publicado: (2022) -
Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1
por: Rhett, J. Matthew, et al.
Publicado: (2011) -
Impact of the Controlled Release of a Connexin 43 Peptide on Corneal Wound Closure in an STZ Model of Type I Diabetes
por: Moore, Keith, et al.
Publicado: (2014)